The Medicines Australia chair rightly called for product case studies. Companies should provide them, but also be prepared to defend them, because history suggests the Government and its officials will scrutinise and test each example.
Examples are important as evidence of the problem, but be prepared to defend them
May 21, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Advocacy group 'pleading' with the NSW Government to establish Men B vaccine program
June 10, 2025 - - Latest News -
New study reveals superior efficacy of cell-based flu vaccine
June 10, 2025 - - Latest News -
Medicines Australia says delayed listings would not be a surprising response
June 10, 2025 - - Latest News -
Companies confirm renewed push for streamlined immunotherapy listing process
June 9, 2025 - - Latest News -
You certainly couldn't accuse this system of haste, and this might need ministerial intervention
June 9, 2025 - - Latest News -
Early intervention on chronic kidney disease would deliver economic boost
June 8, 2025 - - Latest News -
Australian Dementia Network, Monash University and Lilly sign research collaboration
June 6, 2025 - - Latest News